February 13, 2018
LTL Pharma CEO Jiro Mizukawa LTL Pharma is confident about its business specializing in off-patent brand-name medicines despite the major pricing overhaul this April, which would cut sharply into the prices of these drugs called long-listed products (LLPs), President and...read more